Acadian Asset Management
PVLA

Acadian Asset Management’s Palvella Therapeutics, Inc. Common Stock PVLA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$0 Buy
+1
New ﹤0.01% 1874
2025
Q1
Sell
-1,549
Closed -$18K 1844
2024
Q4
$18K Sell
1,549
-1,464
-49% -$17K ﹤0.01% 1549
2024
Q3
$49K Sell
3,013
-7,814
-72% -$127K ﹤0.01% 1798
2024
Q2
$106K Sell
10,827
-951,531
-99% -$9.32M ﹤0.01% 1530
2024
Q1
$175K Hold
962,358
﹤0.01% 1203
2023
Q4
$174K Hold
962,358
﹤0.01% 1258
2023
Q3
$286K Buy
962,358
+378,339
+65% +$112K ﹤0.01% 1128
2023
Q2
$96K Sell
584,019
-46,671
-7% -$7.67K ﹤0.01% 1411
2023
Q1
$615K Sell
630,690
-251,144
-28% -$245K ﹤0.01% 1006
2022
Q4
$916K Buy
881,834
+120,547
+16% +$125K ﹤0.01% 868
2022
Q3
$874K Sell
761,287
-36,220
-5% -$41.6K ﹤0.01% 841
2022
Q2
$1.49M Buy
797,507
+446,718
+127% +$836K 0.01% 711
2022
Q1
$1.06M Buy
350,789
+3,546
+1% +$10.7K ﹤0.01% 815
2021
Q4
$1.31M Buy
347,243
+274,896
+380% +$1.04M ﹤0.01% 762
2021
Q3
$373K Sell
72,347
-86,029
-54% -$444K ﹤0.01% 1131
2021
Q2
$607K Sell
158,376
-643,254
-80% -$2.47M ﹤0.01% 1080
2021
Q1
$2.06M Sell
801,630
-75,735
-9% -$195K 0.01% 724
2020
Q4
$2.19M Sell
877,365
-64,987
-7% -$162K 0.01% 729
2020
Q3
$1.95M Buy
942,352
+162,209
+21% +$336K 0.01% 673
2020
Q2
$2.42M Buy
780,143
+125,233
+19% +$388K 0.01% 685
2020
Q1
$1.49M Buy
654,910
+50,468
+8% +$115K 0.01% 679
2019
Q4
$2.19M Sell
604,442
-1,283,024
-68% -$4.65M 0.01% 656
2019
Q3
$6.43M Sell
1,887,466
-350,554
-16% -$1.19M 0.03% 415
2019
Q2
$10.5M Hold
2,238,020
0.05% 278
2019
Q1
$7.5M Hold
2,238,020
0.03% 363
2018
Q4
$5.96M Buy
2,238,020
+70,793
+3% +$188K 0.03% 348
2018
Q3
$12.1M Buy
2,167,227
+42,354
+2% +$237K 0.05% 261
2018
Q2
$10.8M Buy
2,124,873
+664,032
+45% +$3.37M 0.05% 289
2018
Q1
$9.96M Buy
1,460,841
+1,344,687
+1,158% +$9.17M 0.04% 305
2017
Q4
$877K Buy
116,154
+14,263
+14% +$108K ﹤0.01% 713
2017
Q3
$587K Buy
101,891
+69,789
+217% +$402K ﹤0.01% 766
2017
Q2
$162K Buy
+32,102
New +$162K ﹤0.01% 972